Macrophage Activation Syndrome Upon Initiation of Adalimumab in a Patient With Longstanding Rheumatoid Arthritis

Macrophage activation syndrome (MAS) is a subset of hemophagocytic lymphohistiocytosis (HLH) described in patients with rheumatological disorders. Some triggers of MAS and HLH include infection, malignancy, rheumatological disease, HIV, and rarely medications such as immunosuppressants. In recent me...

Descripción completa

Detalles Bibliográficos
Autores principales: Chicos, Celestin, Zirkiyeva, Milana, Bandagi, Sabiha, Abrudescu, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899127/
https://www.ncbi.nlm.nih.gov/pubmed/33633871
http://dx.doi.org/10.7759/cureus.12825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899127/
https://www.ncbi.nlm.nih.gov/pubmed/33633871
http://dx.doi.org/10.7759/cureus.12825

Ejemplares similares